
Bayer Aktiengesellschaft
Bayer Aktiengesellschaft is a Germany-based company in the Healthcare sector with a market capitalisation of $49.1B. Its FinScore is 60/100; its highest-scoring layer is Quality (80) and its lowest is Growth (25).
Share price performance
About Bayer Aktiengesellschaft
www.bayer.comBayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- HQ
- Germany
- Fiscal year-end
- December
- Trading currency
- EUR
- Reporting currency
- EUR
- Fundamentals updated
- 70 days ago
- Market cap
- $49.1B
- Shares outstanding
- 982.4M
- Dividend yield (TTM)
- 0.25%
- Beta (issuer)
- 0.84
- Revenue (latest FY)
- €45.6B
Revenue breakdown
Revenue split not available
FinScore
As of 2026-10-19Snapshot
Ownership
As of 2026-03-31Sign up or log in to see Analysis
Analysis for Bayer Aktiengesellschaft is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Bayer Aktiengesellschaft is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Bayer Aktiengesellschaft is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Bayer Aktiengesellschaft is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Bayer Aktiengesellschaft is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Bayer Aktiengesellschaft is available to Finryse members. The Overview stays open to everyone; creating an account is free.